Disc Medicine Inc
NASDAQ:IRON
Cash Flow Statement
Cash Flow Statement
Disc Medicine Inc
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(20)
|
(36)
|
(54)
|
(72)
|
(63)
|
(59)
|
(43)
|
(47)
|
(60)
|
(63)
|
(74)
|
(76)
|
(81)
|
(91)
|
(103)
|
(109)
|
(116)
|
(145)
|
(181)
|
(212)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
3
|
5
|
7
|
1
|
(1)
|
(3)
|
(5)
|
2
|
3
|
4
|
5
|
6
|
9
|
11
|
14
|
17
|
19
|
23
|
29
|
34
|
|
| Other Non-Cash Items |
4
|
7
|
9
|
10
|
6
|
7
|
7
|
2
|
3
|
2
|
2
|
6
|
9
|
10
|
10
|
12
|
12
|
15
|
22
|
28
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Change in Working Capital |
0
|
(2)
|
(2)
|
2
|
(2)
|
(3)
|
(6)
|
2
|
(8)
|
(3)
|
4
|
(3)
|
(0)
|
7
|
9
|
3
|
3
|
(4)
|
(5)
|
4
|
|
| Cash from Operating Activities |
(15)
N/A
|
(31)
-103%
|
(47)
-51%
|
(60)
-26%
|
(58)
+2%
|
(55)
+6%
|
(43)
+22%
|
(42)
+1%
|
(64)
-52%
|
(65)
-1%
|
(68)
-5%
|
(73)
-8%
|
(72)
+3%
|
(74)
-4%
|
(84)
-13%
|
(94)
-12%
|
(102)
-8%
|
(134)
-32%
|
(165)
-23%
|
(180)
-10%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(220)
|
(291)
|
(292)
|
(564)
|
(292)
|
(171)
|
(393)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
-29%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-20%
|
(0)
-6%
|
(0)
-26%
|
(0)
+63%
|
(0)
-42%
|
(220)
-174 396%
|
(291)
-32%
|
(292)
0%
|
(565)
-93%
|
(293)
+48%
|
(173)
+41%
|
(394)
-128%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
125
|
125
|
0
|
0
|
0
|
0
|
0
|
54
|
131
|
285
|
285
|
239
|
178
|
197
|
197
|
190
|
419
|
246
|
257
|
473
|
|
| Net Issuance of Debt |
(1)
|
(2)
|
(3)
|
(5)
|
0
|
(5)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
0
|
0
|
0
|
0
|
|
| Other |
194
|
193
|
196
|
196
|
0
|
0
|
0
|
95
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
|
| Cash from Financing Activities |
318
N/A
|
316
-1%
|
193
-39%
|
191
-1%
|
(4)
N/A
|
(5)
-24%
|
(7)
-34%
|
149
N/A
|
226
+52%
|
383
+69%
|
386
+1%
|
239
-38%
|
178
-26%
|
197
+11%
|
197
0%
|
218
+11%
|
447
+105%
|
274
-39%
|
286
+4%
|
473
+66%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
182
N/A
|
164
-10%
|
145
-11%
|
132
-9%
|
(62)
N/A
|
(59)
+5%
|
(49)
+18%
|
107
N/A
|
162
+52%
|
318
+96%
|
318
0%
|
166
-48%
|
106
-36%
|
(97)
N/A
|
(178)
-84%
|
(168)
+6%
|
(220)
-31%
|
(153)
+30%
|
(52)
+66%
|
(101)
-95%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(31)
-103%
|
(47)
-51%
|
(60)
-26%
|
(59)
+2%
|
(55)
+7%
|
(43)
+22%
|
(42)
+1%
|
(64)
-51%
|
(65)
-1%
|
(68)
-5%
|
(74)
-8%
|
(72)
+2%
|
(74)
-4%
|
(84)
-13%
|
(94)
-12%
|
(103)
-9%
|
(136)
-32%
|
(166)
-22%
|
(181)
-9%
|
|